Human mast cells decrease SLPI levels in type II – like alveolar cell model, in vitro

BACKGROUND: Mast cells are known to accumulate at sites of inflammation and upon activation to release their granule content, e.g. histamine, cytokines and proteases. The secretory leukocyte protease inhibitor (SLPI) is produced in the respiratory mucous and plays a role in regulating the activity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollander, Camilla, Nyström, Max, Janciauskiene, Sabina, Westin, Ulla
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194615/
https://www.ncbi.nlm.nih.gov/pubmed/12952550
http://dx.doi.org/10.1186/1475-2867-3-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194615/
https://www.ncbi.nlm.nih.gov/pubmed/12952550
http://dx.doi.org/10.1186/1475-2867-3-14

Ejemplares similares